19-45001685-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_006509.4(RELB):c.106G>A(p.Gly36Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000075 in 1,519,178 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G36E) has been classified as Uncertain significance.
Frequency
Consequence
NM_006509.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RELB | NM_006509.4 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant | 1/12 | ENST00000221452.13 | |
RELB | NM_001411087.1 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant | 1/11 | ||
RELB | XM_005259128.3 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant | 1/11 | ||
RELB | XM_047439189.1 | c.-359G>A | splice_region_variant, 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RELB | ENST00000221452.13 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant | 1/12 | 1 | NM_006509.4 | P2 | |
RELB | ENST00000505236.2 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant | 1/11 | 5 | A2 | ||
RELB | ENST00000509480.5 | c.106G>A | p.Gly36Arg | missense_variant, splice_region_variant, NMD_transcript_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000509 AC: 6AN: 117946Hom.: 0 AF XY: 0.0000154 AC XY: 1AN XY: 64972
GnomAD4 exome AF: 0.0000761 AC: 104AN: 1367032Hom.: 0 Cov.: 28 AF XY: 0.0000653 AC XY: 44AN XY: 674152
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
RELB-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 13, 2022 | The RELB c.106G>A variant is predicted to result in the amino acid substitution p.Gly36Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-45504943-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 36 of the RELB protein (p.Gly36Arg). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RELB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1413689). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at